Immunopathology of coronavirus disease 2019 (COVID-19)
Severe coronavirus disease 2019 (COVID-19) is well known for pneumonia, lymphopenia, exhausted lymphocytes, and a cytokine storm. The significant antibody production whether protective or pathogenic in nature is yet to be determined [1]. Most patients with COVID-19 exhibit mild to moderate symptoms. However, approximately 15% progress to severe pneumonia and 5% eventually develop acute respiratory distress syndrome (ARDS), septic shock, and/or multiple organ failure [2-3].